A B S T RA C T The effects of vitamin D, 2.5 mg (100,000 U)/d for 4 d, on serum calcium, serum 25-hydroxyvitamin D (25-OHD) and serum la,25-dihydroxyvitamin D (la,25(OH)2D) were compared in 24 normal adults and 12 normal children. The daily dose of vitamin D was 1,500 U/kg body wt in children weighing <45 kg. Vitamin D increased mean serum calcium from 9.5±0.1 to 9.8±0.1 mg/dl (P < 0.05), increased mean serum phosphorus from 4.6±0.1 to 5.0±0.1 mg/dl (P < 0.01), increased mean serum 25-OHD from 25±3 to 34±4 ng/ml (P < 0.001), and increased mean serum la,25(OH)2D from 34±3 to 42±4 pg/ml (P < 0.02) in children. In contrast, vitamin D increased mean serum 25-OHD from 18±2 to 39±6 ng/ml (P < 0.001) and did not change mean serum calcium (9.4±0.1 vs. 9.5±0.1 mg/dl), mean serum phosphorus (4.0±0.1 vs. 4.1±0.1 mg/dl), or mean serum la,25(OH)2D (31±2 vs. 29±3 pg/ml) in adults. Mean serum la,25(OH)2D was significantly higher after vitamin D in children than in adults (P < 0.02). These results provide evidence that circulating la,25(OH)2D is not as tightly regulated in children as it is in adults. This difference in regulation could account in part for the higher values for serum la,25(OH)2D observed in children. INTRODUCTION 
1374 sistently higher in normal children and adolescents than in normal adults (1) (2) (3) (4) (5) (6) . It is known that growth hormone secretion is increased in children and adolescents (7) and that intestinal absorption of calcium increases in response to administration of growth hormone (5, 8) . Thus, one explanation could be that the production of la,25(OH)2D is regulated by growth hormone. Short-term studies do not support this possibility (3, 5) . In one investigation, for example, administration of growth hormone to children with deficiency of the hormone increased intestinal absorption of calcium and reduced serum la,25(OH)2D (5).
On the other hand, preliminary long-term studies provide evidence that growth hormone may increase the sensitivity of the kidney to parathyroid hormone and thereby augment circulating la,25(OH)2D (9) . We previously demonstrated tight regulation of circulating la,25(OH)2D in normal adults given pharmacologic doses of vitamin D (10, 11) . One mechanism which could account for higher values for serum la,25(OH)2D in children is that production of the metabolite is not closely regulated. The present studies were carried out to examine this hypothesis. The response of circulating la,25(OH)2D to challenge with vitamin D was compared in children and adults. METHODS 24 normal adult subjects, 10 men and 14 women, ranging in age from 21 to 56 yr, and 12 normal children, 5 boys and 7 girls, ranging in age from 21 mo to 17 yr, were studied.
All except one of the adults were between 21 With few exceptions, the two samples from each subject were measured in the same assay. The mean value in normal adult subjects is 32+2 pg/ml and the normal range is from 12 to 55 pg/ml (n = 33). The 95% confidence values (mean +2 SD) are 13-52 pg/ml. Interassay variation is 9.1% (n = 17). Serum samples were obtained from other normal outpatient subjects, both children and adults, after overnight fast for determination of parathyroid hormone (PTH). Serum immunoreactive PTH was measured by radioimmunoassay with antiserum from chicken 77125 at a final concentration of 1:10,000 (10, 18).
Student's t test was used to determine the significance of differences between paired and unpaired samples (19 Table I . In children, vitamin D produced significant increases in mean serum calcium, serum phosphorus, serum 25-OHD, and serum la,25-(OH)2D. The increases in mean serum 25-OHD and serum la,25(OH)2D averaged 36 and 24%, respectively. In contrast, vitamin D significantly increased mean serum 25-OHD and did not change mean serum Our findings show an unequivocal "impairment" in regulation of circulating la,25(OH)2D in a group of normal children in response to a challenge with pharmacologic doses of vitamin D. There were proportional increases in the concentrations of la,25(OH)2D and of the precursor, 25-OHD, which were associated with significant increases in serum calcium and phosphorus. The results are in clear contrast to those obtained in a group of adults who demonstrated no change in mean serum la,25(OH)2D, mean serum calcium, or Serum 1 a,25-Dihydroxyvitamin D in Childrenmean serum phosphorus, in response to challenge with vitamin D (10, 11) .
It is unlikely that the enhanced response of serum la,25(OH)2D in children is related to an increase in the concentration of circulating PTH. Whereas mean serum immunoreactive PTH was higher in a group of normal children than in a group of normal adults, the difference was not statistically significant. As noted already, however, preliminary evidence in long-term studies in children suggests that growth hormone may increase serum 1a,25(0H)2D by enhancing the renal response to PTH (9) .
The findings in children are qualitatively similar to those we reported previously in patients with sarcoidosis and normal calcium metabolism. When challenged with the same dose of vitamin D, these individuals exhibited a mean twofold increase in serum la,25(OH)2D (11) . Also, glucocorticoids decreased serum la,25(OH)2D in children (20) and, when given for 8 d, lowered serum la,25(OH)2D in patients with sarcoid who were normocalcemic (21), but did not alter serum la,25(OH)2D in normal adults (21) . When given for 14 d to adults, glucocorticoids increased serum la,25(OH)2D and lowered the fractional intestinal absorption of calcium (22) .
The question of extrarenal production of la,25(OH)2D was raised in sarcoid because of the demonstration of increased serum la,25(OH)2D (which correlated with the serum calcium) and suppressed serum immunoreactive PTH in a patient with the disorder who had undergone bilateral nephrectomy (23) . In this regard, recent preliminary studies showed that a positive correlation existed between serum 25-OHD and serum la,25(OH)2D in children with chronic renal disease who were undergoing treatment with 25-OHD3 only when the glomerular filtration rate was c 25 ml/min (24) . The findings in these patients could be interpreted to mean that there is extrarenal synthesis of la,25(OH)2D that is not closely regulated. These and the present observations suggest that children may have either a different control mechanism for regulation of renal synthesis of the metabolite as compared to adults, extrarenal production of la,25(OH)2D, or some combination of these possibilities. Our findings do not allow us to distinguish among these alternatives.
Whatever the mechanism, our results showing lack of tight regulation of circulating la,25(OH)2D provide a possible explanation for the higher serum values of this metabolite in normal children and adolescents as compared to adults (1) (2) (3) (4) (5) (6) .
